Acer Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Acer Therapeutics

17/11/2022 23:01

* Acer Therapeutics Inc  ACER.OQ  reported a quarterly
adjusted
loss of 31 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 68 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Acer Therapeutics Inc's reported EPS for the quarter was a
loss
of 31 cents​.
    * The mean earnings estimate of analysts had risen by
about 24.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Acer Therapeutics Inc shares had fallen by 15.8% this
quarter and lost 48.7% so far this year.
    * The company reported a quarterly loss of $5.01 million.
    * Wall Street's median 12-month price target for Acer
Therapeutics
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
17 at 11:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.68          -0.31          Beat
 Jun. 30 2022      -0.57          -0.17          Beat
 Mar. 31 2022      -0.41          -0.64          Missed
 Dec. 31 2021      -0.01          -0.31          Missed